These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31752396)

  • 1. Synthesis and Antimicrobial Activity of Some New Substituted Quinoxalines.
    El-Atawy MA; Hamed EA; Alhadi M; Omar AZ
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31752396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antimicrobial activity of certain novel quinoxalines.
    Refaat HM; Moneer AA; Khalil OM
    Arch Pharm Res; 2004 Nov; 27(11):1093-8. PubMed ID: 15595408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation for biological activity of 3-alkyl and 3-halogenoalkyl-quinoxalin-2-ones variously substituted. Part 4.
    Carta A; Sanna P; Loriga M; Setzu MG; La CP; Loddo R
    Farmaco; 2002 Jan; 57(1):19-25. PubMed ID: 11902641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel functionalized pyrido[2,3-g]quinoxalinones as antibacterial, antifungal and anticancer agents.
    Carta A; Sanna P; Gherardini L; Usai D; Zanetti S
    Farmaco; 2001 Dec; 56(12):933-8. PubMed ID: 11829113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antimicrobial testing of thiazolinyl-, thiazolidinonyl-quinoxalines and 1,2,4-triazolo[4,3-a]quinoxalines.
    Habib NS; el-Hawash SA
    Pharmazie; 1997 Aug; 52(8):594-8. PubMed ID: 9292917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of some new quinoxalines and 1,2,4-triazolo[4,3-a]-quinoxalines for evaluation of in vitro antitumor and antimicrobial activities.
    El-Hawash SA; Habib NS; Kassem MA
    Arch Pharm (Weinheim); 2006 Oct; 339(10):564-71. PubMed ID: 17009301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinoxaline derivatives. Part II: Synthesis and antimicrobial testing of 1,2,4-triazolo[4,3-a]quinoxalines, 1,2,4-triazino[4,3-a]quinoxalines and 2-pyrazolylquinoxalines.
    el-Hawash SA; Habib NS; Fanaki NH
    Pharmazie; 1999 Nov; 54(11):808-13. PubMed ID: 10603606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microwave assisted synthesis and antimicrobial activity of 2-quinoxalinone-3-hydrazone derivatives.
    Ajani OO; Obafemi CA; Nwinyi OC; Akinpelu DA
    Bioorg Med Chem; 2010 Jan; 18(1):214-21. PubMed ID: 19948407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure elucidation of some new thioether derivatives of 1,2,4-triazoline-3-thiones and their antimicrobial activities.
    Gülerman NN; Dogan HN; Rollas S; Johansson C; Celik C
    Farmaco; 2001 Dec; 56(12):953-8. PubMed ID: 11829116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New methyl-quinoxaline derivatives with antimicrobial activity].
    Ungureanu M; Poiată A; Tuchiluş C
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):181-4. PubMed ID: 15688781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of some new amide moiety bearing quinoxaline derivatives as antimicrobial agents.
    Abu Mohsen U; Yurttaş L; Acar U; Özkay Y; Kaplacikli ZA; Karaca Gencer H; Cantürk Z
    Drug Res (Stuttg); 2015 May; 65(5):266-71. PubMed ID: 24918343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinoxalin-2-ones. Part 5. Synthesis and antimicrobial evaluation of 3-alkyl-, 3-halomethyl- and 3-carboxyethylquinoxaline-2-ones variously substituted on the benzo-moiety.
    Carta A; Loriga M; Zanetti S; Sechi LA
    Farmaco; 2003 Dec; 58(12):1251-5. PubMed ID: 14630235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of antimicrobial 2,9,10-trisubstituted-6-oxo-7,12-dihydro-chromeno[3,4-b]quinoxalines.
    Kotharkar SA; Shinde DB
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6181-4. PubMed ID: 17027265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro-anticancer and antimicrobial evaluation of some novel quinoxalines derived from 3-phenylquinoxaline-2(1H)-thione.
    El-Hawash SA; Wahab AE
    Arch Pharm (Weinheim); 2006 Aug; 339(8):437-47. PubMed ID: 16881038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in design of potential quinoxaline anti-infectives.
    Jampilek J
    Curr Med Chem; 2014; 21(38):4347-73. PubMed ID: 25312209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo assessment of newer quinoxaline-oxadiazole hybrids as antimicrobial and antiprotozoal agents.
    Patel NB; Patel JN; Purohit AC; Patel VM; Rajani DP; Moo-Puc R; Lopez-Cedillo JC; Nogueda-Torres B; Rivera G
    Int J Antimicrob Agents; 2017 Sep; 50(3):413-418. PubMed ID: 28687457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antimicrobial activity of 7-(2-substituted phenylthiazolidinyl)-benzopyran-2-one derivatives.
    Ronad PM; Noolvi MN; Sapkal S; Dharbhamulla S; Maddi VS
    Eur J Med Chem; 2010 Jan; 45(1):85-9. PubMed ID: 19837487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, Characterization and Biological Evaluation of Some Quinoxaline Derivatives: A Promising and Potent New Class of Antitumor and Antimicrobial Agents.
    Al-Marhabi AR; Abbas HA; Ammar YA
    Molecules; 2015 Nov; 20(11):19805-22. PubMed ID: 26540036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization and antimicrobial activity of some disubstituted 1,3,4-oxadiazoles carrying 2-(aryloxymethyl)phenyl moiety.
    Naveena CS; Boja P; Kumari NS
    Eur J Med Chem; 2010 Nov; 45(11):4708-19. PubMed ID: 20728250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 3,6,7-substituted-quinoxalin-2-ones for evaluation of antimicrobial and anticancer activity. Part 2.
    Sanna P; Carta A; Loriga M; Zanetti S; Sechi L
    Farmaco; 1999 Mar; 54(3):161-8. PubMed ID: 10371029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.